SCHEMBL1702687

SCHEMBL1702687

CCOC(=O)C1=C/C(=N/O)CC(c2ccc(Cl)cc2)N1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCC1 P33527 1/20 0.46
ALOX12 P18054 2/20 0.45
HTT P42858 2/20 0.45
LMNA P02545 2/20 0.45
ALDH1A1 P00352 2/20 0.44
GAA P10253 1/20 0.44
NPSR1 Q6W5P4 5/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
HPGD P15428 2/20 0.43
CACNA1D Q01668 1/20 0.41
TP53 P04637 3/20 0.40
TSHR P16473 1/20 0.40
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
CA12 O43570 2/20 0.39
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
CA7 P43166 2/20 0.39
CA9 Q16790 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1702689 1.00 ABCC1 (0.46) ABCC1ALOX12HTTLMNAALDH1A1
SCHEMBL3770516 0.85 ABCC1 (0.41) ABCC1ALOX12HTTLMNAALDH1A1
SCHEMBL3770518 0.85 ABCC1 (0.41) ABCC1ALOX12HTTLMNAALDH1A1
SCHEMBL1703162 0.84 ABCC1 (0.49) ABCC1ALOX12HTTLMNAALDH1A1
SCHEMBL12011131 0.83 ABCC1 (0.48) ABCC1ALOX12HTTLMNAALDH1A1
SCHEMBL1703055 0.83 MAPK1 (0.43) ABCC1ALOX12HTTLMNAALDH1A1
SCHEMBL1703053 0.83 MAPK1 (0.43) ABCC1ALOX12HTTLMNAALDH1A1
SCHEMBL3763795 0.72 SLC6A3 (0.38) LMNAALDH1A1GAANPSR1HPGD
SCHEMBL1703036 0.70 HPGD (0.45) ALOX12HTTLMNAALDH1A1GAA
SCHEMBL3765253 0.70 TLR4 (0.40) LMNAALDH1A1GAASMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2440526-B1 3-HALO-6-(ARLY)-4-IMINOTETRAHYDROPICOLINATES AND THEIR USE AS HERBICIDES DOW AGROSCIENCES LLC (US) 2014-11-12 EP disclosed
US-8598086-B2 3-halo-(arly)-4-iminotetrahydropicolinates and their use as herbicides DOW AGROSCIENCES, LLC. (US) 2013-12-03 US disclosed
EP-2440530-B1 PROCESS FOR THE PREPARATION OF 6-(ARYL)-4-AMINOPICOLINATES DOW AGROSCIENCES LLC (US) 2013-07-24 EP disclosed
US-8252938-B2 Process for the preparation of 6-(aryl)-4-aminopicolinates DOW AGROSCIENCES, LLC. (US) 2012-08-28 US disclosed
EP-2440530-A1 PROCESS FOR THE PREPARATION OF 6-(ARYL)-4-AMINOPICOLINATES Dow AgroSciences LLC (US) 2012-04-18 EP disclosed
EP-2440526-A1 3-HALO-6-(ARLY)-4-IMINOTETRAHYDROPICOLINATES AND THEIR USE AS HERBICIDES Dow AgroSciences LLC (US) 2012-04-18 EP disclosed
WO-2010144380-A1 PROCESS FOR THE PREPARATION OF 6-(ARYL)-4-AMINOPICOLINATES DOW AGROSCIENCES LLC (US) 2010-12-16 WO disclosed
WO-2010144379-A1 3-HALO-(ARLY)-4-IMINOTETRAHYDROPICOLINATES AND THEIR USE AS HERBICIDES DOW AGROSCIENCES LLC (US) 2010-12-16 WO disclosed
US-20100311594-A1 3-HALO-(ARLY)-4-IMINOTETRAHYDROPICOLINATES AND THEIR USE AS HERBICIDES DOW AGROSCIENCES LLC (US) 2010-12-09 US disclosed
US-20100311981-A1 PROCESS FOR THE PREPARATION OF 6-(ARYL)-4-AMINOPICOLINATES DOW AGROSCIENCES LLC (US) 2010-12-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100311981-A1 PROCESS FOR THE PREPARATION OF 6-(ARYL)-4-AMINOPICOLINATES HTR6, CYP46A1, NISCH ABCC1 4213/4885ALOX12 3172/4885HTT 93/4885
US-20100311594-A1 3-HALO-(ARLY)-4-IMINOTETRAHYDROPICOLINATES AND THEIR USE AS HERBICIDES HDHD5, ATL3, HCAR3 ABCC1 1583/4885ALOX12 2752/4885HTT 67/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.